C. Pilop

Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.

P. Manser, G. Hildebrandt, M. Guckenberger, 2013, International journal of radiation oncology, biology, physics.

Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09.

L. Bubendorf, R. Stahel, S. Peters, 2015, Clinical lung cancer.

Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with estrogen receptor-positive, HER-2-positive advanced breast cancer: a proof-of-concept trial (SAKK 23/03).

K. Zaman, T. Ruhstaller, L. Jost, 2011, Endocrine-related cancer.

Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients

B. Thürlimann, H. Hawle, C. Sessa, 2017, Endocrine connections.

Urinary proteomics before and after extracorporeal circulation in patients with and without acute kidney injury.

T. Carrel, F. Frey, B. Frey, 2010, The Journal of thoracic and cardiovascular surgery.

Proteomic Analysis in Aortic Media of Patients With Marfan Syndrome Reveals Increased Activity of Calpain 2 in Aortic Aneurysms

J. Gorman, R. Gorman, B. Gerrits, 2009, Circulation.

Abstract P5-14-05: Phase 1 evaluation of the androgen receptor modulator CR1447 in patients with advanced breast cancer (SAKK 21/12)

M. Zweifel, C. Tapia, P. Brauchli, 2016 .